← Leaderboards
S Michael Mauer
University Of Minnesota Twin Cities
$32,717,497
Attributed
$49,170,371
Total exposure
15
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $24.9M · FY2005–24$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$49,170,371 · 15
By mechanism
UC4$31,562,202 · 1
R01$11,576,735 · 3
U01$2,180,859 · 1
R21$1,000,596 · 2
P01$953,073 · 1
T32$809,536 · 1
Top collaborators
- Alessandro Doria8 shared
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Michael S Mauer$2,199,497
- Brian David Ross$4,494,753
- Ulrike Gertrud Munderloh$20,215,521
- Arthur J Matas$28,561,331
- Rolf Gruetter$3,406,414
Others in their field
Top investigators on “Diabetic Nephropathy”
- John M Lachin · George Washington University$140,240,809
- David M Nathan · Massachusetts Institute Of Technology$119,524,803
- Rose A Gubitosi-Klug · Case Western Reserve University$70,295,008
- Billy Gerald Hudson · Vanderbilt University Medical Center$27,051,004
- Alessandro Doria · Joslin Diabetes Center$19,651,882
- Jose Carlos Florez · Massachusetts General Hospital$16,609,052
Research focus
Diabetic NephropathyBiopsyClinical ResearchInsulin Dependent Diabetes MellitusKidneyGlomerular Filtration RateEnd Stage Renal FailureHuman SubjectBlood PressureKidney FailureResidual StateBiomarkerDiabetes MellitusClinical TrialsInsulin-Dependent Diabetes MellitusLesionTissue /Cell CultureProteinuriaNatural HistoryResearch PersonnelFibroblastsRenal FunctionStagingPlasma
Grant awards (61)
Cardiac and Arteriolar Lesions in Fabry Disease and Dysautonomia$107,702
U54 · FY2024 · NS · contact PI
A pilot study of fenofibrate to prevent kidney function loss in type 1 diabetes$341,580
R01 · FY2023 · DK
Cardiac and Arteriolar Lesions in Fabry Disease and Dysautonomia$168,668
U54 · FY2023 · NS · contact PI
A pilot study of fenofibrate to prevent kidney function loss in type 1 diabetes$330,098
R01 · FY2022 · DK
Cardiac and Arteriolar Lesions in Fabry Disease and Dysautonomia$168,749
U54 · FY2022 · NS · contact PI
A pilot study of fenofibrate to prevent kidney function loss in type 1 diabetes$375,469
R01 · FY2021 · DK
Cardiac and Arteriolar Lesions in Fabry Disease and Dysautonomia$168,832
U54 · FY2020 · NS · contact PI
Cardiac and Arteriolar Lesions in Fabry Disease and Dysautonomia$177,019
U54 · FY2019 · NS · contact PI
PERL: A multi-center clinical trial of allopurinol to prevent GFR loss in T1D$250,000
UC4 · FY2018 · DK
PERL: A multi-center clinical trial of allopurinol to prevent GFR loss in T1D$7,000,000
UC4 · FY2017 · DK
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D$24,312,202
UC4 · FY2013 · DK
Urinary Biomarkers in Biopsy Defined Early Nephropathy in Types 1 and 2 Diabetes$444,225
U01 · FY2013 · DK · contact PI
Diabetic Nephropathy$192,731
P01 · FY2013 · DK · contact PI
Urinary Biomarkers in Biopsy Defined Early Nephropathy in Types 1 and 2 Diabetes$432,546
U01 · FY2012 · DK · contact PI
Diabetic Nephropathy$198,803
P01 · FY2012 · DK · contact PI
A multicenter clinical trial of allopurinol to prevent GFR loss in T1D$189,720
R34 · FY2012 · DK
Urinary Biomarkers in Biopsy Defined Early Nephropathy in Types 1 and 2 Diabetes$421,207
U01 · FY2011 · DK · contact PI
Diabetic Nephropathy$181,127
P01 · FY2011 · DK · contact PI
Design of a Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D$106,680
R03 · FY2011 · DK
Urinary Biomarkers in Biopsy Defined Early Nephropathy in Types 1 and 2 Diabetes$386,128
U01 · FY2010 · DK · contact PI
Diabetic Nephropathy$175,182
P01 · FY2010 · DK · contact PI
Urinary Biomarkers in Biopsy Defined Early Nephropathy in Types 1 and 2 Diabetes$100,000
U01 · FY2010 · DK · contact PI
Urinary Biomarkers in Biopsy Defined Early Nephropathy in Types 1 and 2 Diabetes$396,753
U01 · FY2009 · DK · contact PI
Diabetic Nephropathy$205,230
P01 · FY2009 · DK · contact PI
Renal & Cellular Studies in Type 1 Diabetic Patients$638,129
R01 · FY2007 · DK · contact PI
Renin Angiotensin System Blockage-DN (RASS)$447,399
R01 · FY2007 · DK · contact PI
Mitochondrial and Oxidative Stress in Type 1 Diabetes$123,546
R21 · FY2007 · DK · contact PI
Renin Angiotensin System Blockage-DN (RASS)$880,592
R01 · FY2006 · DK · contact PI
Renal & Cellular Studies in Type 1 Diabetic Patients$638,429
R01 · FY2006 · DK · contact PI
Mitochondrial and Oxidative Stress in Type 1 Diabetes$134,550
R21 · FY2006 · DK · contact PI
Renin Angiotensin System Blockage-DN (RASS)$74,750
R01 · FY2006 · DK · contact PI
Renin Angiotensin System Blockage-DN (RASS)$1,228,133
R01 · FY2005 · DK
Renal &Cellular Studies in Type 1 Diabetic Patients$643,489
R01 · FY2005 · DK
Proteomics in Type 1 Diabetes and its Complications$371,250
R21 · FY2005 · DK
Renin Angiotensin System Blockage-DN (RASS)$1,140,996
R01 · FY2004 · DK
Renal &Cellular Studies in Type 1 Diabetic Patients$612,594
R01 · FY2004 · DK
Proteomics in Type 1 Diabetes and its Complications$371,250
R21 · FY2004 · DK
PREFACULTY TRAINING IN PEDIATRIC NEPHROLOGY$125,607
T32 · FY2004 · DK
Renin Angiotensin System Blockage-DN (RASS)$1,149,666
R01 · FY2003 · DK
RENIN ANGIOTENSIN SYSTEM BLOCKAGE--DIABETIC NEPHROPATHY$226,632
R01 · FY2003 · DK
PREFACULTY TRAINING IN PEDIATRIC NEPHROLOGY$121,349
T32 · FY2003 · DK
Renin Angiotensin System Blockage-DN (RASS)$74,250
R01 · FY2003 · DK
RENAL AND CELLULAR STUDIES IN TYPE I DIABETIC PATIENTS$61,229
R01 · FY2003 · DK
RENIN ANGIOTENSIN SYSTEM BLOCKAGE--DIABETIC NEPHROPATHY$700,000
R01 · FY2002 · DK
RENAL AND CELLULAR STUDIES IN TYPE I DIABETIC PATIENTS$320,954
R01 · FY2002 · DK
PREFACULTY TRAINING IN PEDIATRIC NEPHROLOGY$196,458
T32 · FY2002 · DK
FACTORS PREDISPOSING DIABETIC PATIENTS TO NEPHROPATHY$0
M01 · FY2002 · RR
RENAL AND CELLULAR STUDIES IN TYPE I DIABETIC PATIENTS$0
M01 · FY2002 · RR
RENAL AND CELLULAR STUDIES IN TYPE I DIABETIC PATIENTS$0
M01 · FY2002 · RR
FACTORS PREDISPOSING DIABETIC PATIENTS TO NEPHROPATHY$0
M01 · FY2002 · RR
RENIN ANGIOTENSIN SYSTEM BLOCKAGE--DIABETIC NEPHROPATHY$570,376
R01 · FY2001 · DK
RENAL AND CELLULAR STUDIES IN TYPE I DIABETIC PATIENTS$315,116
R01 · FY2001 · DK
PREFACULTY TRAINING IN PEDIATRIC NEPHROLOGY$213,971
T32 · FY2001 · DK
RENAL AND CELLULAR STUDIES IN TYPE I DIABETIC PATIENTS$0
M01 · FY2001 · RR
FACTORS PREDISPOSING DIABETIC PATIENTS TO NEPHROPATHY$0
M01 · FY2001 · RR
RENIN ANGIOTENSIN SYSTEM BLOCKAGE--DIABETIC NEPHROPATHY$501,347
R01 · FY2000 · DK
RENAL AND CELLULAR STUDIES IN TYPE I DIABETIC PATIENTS$305,507
R01 · FY2000 · DK
PREFACULTY TRAINING IN PEDIATRIC NEPHROLOGY$100,017
T32 · FY2000 · DK
PREFACULTY TRAINING IN PEDIATRIC NEPHROLOGY$52,134
T32 · FY2000 · DK
RENAL AND CELLULAR STUDIES IN TYPE I DIABETIC PATIENTS$0
M01 · FY2000 · RR
FACTORS PREDISPOSING DIABETIC PATIENTS TO NEPHROPATHY$0
M01 · FY2000 · RR